Navigation Links
Dietary calcium could possibly prevent the spread of breast cancer to bone
Date:10/2/2007

PHILADELPHIA A strong skeleton is less likely to be penetrated by metastasizing cancer cells, so a fortified glass of milk might be the way to block cancers spread, according to researchers at the ANZAC Research Institute in Concord, Australia. Using a mouse model of breast cancer metastasis, the researchers found that a calcium deficiency may increase the tendency of advanced breast cancer to target bone. Dietary calcium, they reason, might help prevent the spread of breast cancer to bone and serve as an adjuvant treatment during therapy.

Their findings are presented in the Oct. 1 issue of Cancer Research, a journal of the American Association for Cancer Research.

According to the researchers, about 70 percent of patients who develop advanced breast cancer will have secondary tumors in the bone. The spread of cancer to bones leads to cellular processes that physically break down existing bone, leading to further pain and illness. In fact, the breakdown of bone and subsequent bone re-growth forms what senior author Colin R. Dunstan, Ph.D., terms a vicious cycle that turns bone into an environment conducive to cancer growth.

To better understand the role of bone turnover in the spread of cancer, Dunstan and his team compared the effects of a low- and high-calcium diet in mice. They found that dietary calcium deficiency independent of the chemical factors that control turnover was related to a significantly higher increase in cancer cell proliferation and the total proportion of bone that had been penetrated.

These results could have implications for patients with breast cancer bone metastases or who are at high risk for developing metastatic disease, Dunstan said. Many older women in our community are known to be calcium deficient due to low calcium dietary intake or due to vitamin D deficiency. These women could be at increased risk for the devastating effects of bone metastases.

According to Dunstan, his results call for further, directed clinical trials to investigate how calcium and vitamin D status influence progression to metastatic disease, and to determine if corrections of calcium and vitamin D deficiencies are important in breast cancer patients.


'/>"/>

Contact: Greg Lester
greg.lester@aacr.org
267-646-0554
American Association for Cancer Research
Source:Eurekalert

Related biology news :

1. Eat less, weigh more? Enzyme makes lean mice susceptible to dietary fat
2. ASU research shows connection between testosterone, dietary antioxidants and bird coloration
3. Major WHO study concludes calcium supplements can reduce complications during pregnancy
4. Protein discovery could unlock the secret to better TB treatment
5. Tiny particles could solve billion-dollar problem
6. Novel Therapy Tested in Mice Could Chase Away Cat Allergies
7. Spider Venom Could Yield Eco-Friendly Insecticides
8. First atlas of key brain genes could speed research on cancer, neurological diseases
9. Discovery of key proteins shape could lead to improved bacterial pneumonia vaccine
10. A comprehensive response to HIV could prevent 10 million AIDS deaths in Africa by 2020
11. New Breast Cancer Test Could Save Lives
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/9/2016)... Mass., Feb. 9, 2016 Aware, Inc. (NASDAQ: AWRE ... financial results for its fourth quarter and year ended December 31, ... for the fourth quarter of 2015 was $6.9 million, an increase ... year. Operating income in the fourth quarter of 2015 was $2.6 ... --> --> Higher revenue ...
(Date:2/5/2016)... DUBLIN , Feb. 5, 2016 /PRNewswire/ ... the addition of the "Global Facial ... offering. --> http://www.researchandmarkets.com/research/5kvw8m/global_facial ) has ... Facial Recognition Market 2016-2020" report to ... Markets ( http://www.researchandmarkets.com/research/5kvw8m/global_facial ) has announced the ...
(Date:2/3/2016)... , February 3, 2016 ... market research report "Automated Fingerprint Identification System Market by ... Search), Application (Banking & Finance, Government, Healthcare, and Transportation) ... MarketsandMarkets, the market is expected to be worth USD ... 21.0% between 2015 and 2020. The transformation and technology ...
Breaking Biology News(10 mins):
(Date:2/12/2016)... , Feb. 12, 2016 Biocom, the association representing ... took a group of San Diego ... of its 2016 Precision Medicine Advocacy Fly-In. Biocom Fly-In participants ... and Drug Administration (FDA), the Centers for Medicare and Medicaid ... as San Diego U.S. Representatives Susan Davis and ...
(Date:2/12/2016)... N.J. , Feb. 12, 2016  PTC ... the second annual STRIVE (Strategies to Realize Innovation, ... muscular dystrophy (DMD). STRIVE provides funds to patient ... that will make meaningful contributions to the rare ... fostering development of future patient advocates. ...
(Date:2/11/2016)... 2016  Neurocrine Biosciences, Inc. (NASDAQ: NBIX ) today announced ... 2015. --> --> For ... of $29.3 million, or $0.34 loss per share, compared to a ... the same period in 2014. For the year ended December 31, ... $1.05 loss per share, as compared to a net loss of ...
(Date:2/11/2016)... , Feb. 11, 2016  Bioethics International, a not-for-profit ... are researched, developed, marketed and made accessible to patients around ... Open had named the publication of the Good ... The publication is also featured as one of BMJ ... the last year that are most frequently read. ...
Breaking Biology Technology: